Serum from endometriosis patients impairs the development of mouse embryos in vitro - Comparison with serum from tubal obstruction patient and plasmanate

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 10, 1996, Pages 877-880

  Ito, Fumitosi ^a   Fujino, Yuji ^a   Ogita, Sachio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Culture medium; Embryo development; Endometriosis; In vitro fertilization; Protein supplement

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; ENDOMETRIOSIS; FEMALE; FERTILIZATION; HUMAN; MOUSE; NONHUMAN; OOCYTE CLEAVAGE; PLASMA; PRIORITY JOURNAL; SERUM; UTERINE TUBE OCCLUSION;

EID: 0030445857     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609055020     Document Type: Article

References (14)

1. Abu-Musa A, Takahashi K, Kitao M. The effect of serum obtained before and after treatment for endometriosis on in vitro development of two-cell mouse embryos. Fertil Steril 1992; 57: 1098-102.
2. Damewood MD. The association of endometriosis and repetitive (early) spontaneous abortion. Semin Reprod Endocrinol 1989; 7: 155-60.
3. Simon C, De los Santos MJ, Gomez E, Pellicer A, Mir A. Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patient. Fertil Steril 1992; 58: 284-9.
4. Adler A, Reing M, Bedford JM, Alikani M, Cohen J. Plasmanate as a medium supplement for in vitro fertilization. J Asst Reprod Genet 1993; 10: 67-71.
5. The American Fertility Society. Revised American Fertility Society classification of endometriosis: Fertil Steril 1989; 43: 351-2.
6. Soules MR, Malinak LR, Bury R, Poindexter A. Endometriosis and anovulation: A coexisting problem in the infertile female. Am J Obstet Gynecol 1967; 125: 412-7.
7. Croxato HB, Oritiz ME, Guiloff E, Ibarra A, Salvatierra AM, Croxatto HD et al. Effect of 15(S)-15-methyl prostaglandin F2a on human oviductal motility and ovum transport. Fertil Steril 1978; 30: 408-14.
8. Brosens IA, Koninckx PR, Corvelyn PA. A study of plasma progesterone, oestradiol-17, prolactin and LH levels, and of the luteal phase appearance of the ovaries in patients with endometriosis and infertility. Br J Obstet Gynaecol 1978; 85: 246-50.
9. Weed JC, Arquembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980; 23: 885-93.
10. Ylikorkala O, Koskimiees A, Laatikainen T, Tenhunen A, Viinikka L. Peritoneal fluid prostaglandins in endometriosis, tubal disorders and unexplained infertility. Obstet Gynecol 1984; 63: 616-20.
11. Wheeler JM, Johnston BM, Malinak LR. The relationship of endometriosis to spontaneous abortion. Fertil Steril 1983; 39: 656-60.
12. Damewood MD, Hubbard M, Hesla JS, Gearhart JD, Schlaff WD, Rock JA. Effect of serum from patients with minimal to mild endometriosis on mouse embryo development in vitro. Fertil Steril 1990; 54: 917-20.
13. Dokras A, Sargent IL, Redman CWG, Barow DH. Sera from women with unexplained infertility inhibit both mouse and human embryo growth in vitro. Fertil Steril 1993; 60: 285-92.
14. Pool TB, Martin JE. High continuing pregnancy rates after in vitro fertilization-embryo transfer using medium supplemented with a plasma protein fraction containing alpha-and beta-globulins. Fertil Steril 1994; 61: 714-9.